> top > docs > PMC:7268883 > spans > 6038-9127 > annotations

PMC:7268883 / 6038-9127 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
115 277-289 Species denotes participants Tax:9606
117 609-617 Disease denotes COVID-19 MESH:C000657245
123 807-815 Species denotes patients Tax:9606
124 650-658 Disease denotes COVID-19 MESH:C000657245
125 820-828 Disease denotes COVID-19 MESH:C000657245
126 926-934 Disease denotes COVID-19 MESH:C000657245
127 1052-1060 Disease denotes COVID-19 MESH:C000657245
129 1316-1324 Disease denotes COVID-19 MESH:C000657245
131 1924-1932 Species denotes patients Tax:9606
140 3007-3010 Gene denotes ten Gene:6503
141 2976-2979 Gene denotes Ta Gene:6503
142 2945-2948 Gene denotes agr Gene:6503
143 2357-2365 Species denotes patients Tax:9606
144 2534-2541 Species denotes patient Tax:9606
145 2679-2687 Species denotes patients Tax:9606
146 2699-2707 Disease denotes COVID-19 MESH:C000657245
147 2889-2897 Disease denotes COVID-19 MESH:C000657245

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T59 609-617 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T60 650-658 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T61 820-828 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T62 926-934 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T63 1052-1060 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T64 1316-1324 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T65 2699-2707 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T66 2889-2897 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T21 22-23 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T22 485-487 http://purl.obolibrary.org/obo/CLO_0001000 denotes 35
T23 680-683 http://purl.obolibrary.org/obo/CLO_0054057 denotes 181
T24 2181-2183 http://purl.obolibrary.org/obo/CLO_0054055 denotes 71
T25 2375-2384 http://purl.obolibrary.org/obo/BFO_0000030 denotes objective
T26 2996-3003 http://www.ebi.ac.uk/efo/EFO_0000881 denotes Digital

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T2 2021-2026 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T43 0-7 Sentence denotes RESULTS
T44 9-21 Sentence denotes Participants
T45 22-133 Sentence denotes A total of 337 respondents from 267 centers and 37 countries spanning 5 continents completed the online survey.
T46 134-187 Sentence denotes See Figure 1 for the number of responses per country.
T47 188-321 Sentence denotes Most respondents were working in an academic center (n = 286, 84.9%) and the majority of participants were surgeons (n = 302, 89.6%).
T48 322-377 Sentence denotes See Table 1 for the characteristics of the respondents.
T49 378-514 Sentence denotes The median annual hospital and individual surgeon volume of pancreatic resections were 75 (IQR 46–140) and 35 (IQR 20–60), respectively.
T50 515-557 Sentence denotes FIGURE 1 Number of responses per country.
T51 558-597 Sentence denotes TABLE 1 Characteristics of Respondents
T52 599-626 Sentence denotes Impact of COVID-19 Pandemic
T53 627-757 Sentence denotes During the peak of the COVID-19 pandemic, 67.8% (n = 181) of centers prioritized between different types of pancreatic resections.
T54 758-892 Sentence denotes Before pancreatic surgery, most centers screened patients for COVID-19 (n = 233, 87.3%), whereas some centers did not (n = 31, 11.6%).
T55 893-954 Sentence denotes See Table 2 for the preoperative COVID-19 screening strategy.
T56 955-1070 Sentence denotes The majority of centers (n = 166, 62.2%) performed less pancreatic surgery as consequence of the COVID-19 pandemic.
T57 1071-1189 Sentence denotes From these centers, the weekly numbers of pancreatic resections decreased from 3 (IQR 2–5) to 1 (IQR 0–2) (P < 0.001).
T58 1190-1279 Sentence denotes In addition, 30.7% (n = 51) of responding centers performed no pancreatic surgery at all.
T59 1280-1324 Sentence denotes TABLE 2 Preoperative Screening for COVID-19
T60 1326-1336 Sentence denotes Statements
T61 1337-1452 Sentence denotes Consensus was reached on 13 from the 21 statements (62%) and moderate agreement was achieved on 5 statements (24%).
T62 1453-1502 Sentence denotes The remaining 3 statements had an agreement <60%.
T63 1503-1548 Sentence denotes See Tables 3 to 5 for the statement outcomes.
T64 1549-1586 Sentence denotes TABLE 3 Statement Outcomes—Consensus
T65 1587-1633 Sentence denotes TABLE 4 Statement Outcomes—Moderate Agreement
T66 1634-1676 Sentence denotes TABLE 5 Statement Outcomes——Low Agreement
T67 1678-1698 Sentence denotes Sensitivity Analyses
T68 1699-1830 Sentence denotes The statement outcomes barely changed after excluding the nonacademic centers, without any shifts in the 3 categories of agreement.
T69 1831-2054 Sentence denotes Exclusion of nonsurgeons lead to the movement of statement 5—regarding the prioritization of patients with limited/without comorbidity for surgery to increase the ICU capacity—to the lowest group of agreement (61.1%–59.9%).
T70 2055-2242 Sentence denotes Analyzing the outcomes of Europe (n = 149, 44.2%), Asia (n = 115, 34.1%), and the Americas (ie, North and South America) (n = 71, 21.1%) separately demonstrated some changes in agreement.
T71 2243-2420 Sentence denotes The European respondents did not reach consensus on statement 3 (76.5% agreement) regarding the prioritization of patients based on objective prognostic factors and comorbidity.
T72 2421-2594 Sentence denotes In contrast to the overall outcomes, Asia achieved consensus on statement 4 (81.7% agreement) to prioritize each patient for pancreatic surgery, based on prognostic factors.
T73 2595-2839 Sentence denotes Whereas Europe agreed on the importance of high-volume centers to operate high-risk patients during the COVID-19 pandemic (87.9% agreement), both Asia (75.7% agreement) and the Americas (76.1% agreement) did not reach consensus on statement 16.
T74 2840-2972 Sentence denotes The recommendation for preoperative screening on COVID-19 (statement 19) reached solely consensus (84.5% agreement) in the Americas.
T75 2973-3089 Sentence denotes See Table—Supplemental Digital Content 2–4, for the statement outcomes of Europe, Asia, and the Americas separately.